Cardiovascular
Cardiovascular-related morbidity and mortality remain the world’s number one killer. Innovators across healthcare sectors are working to change this reality, through novel modalities and mechanisms, precision medicine approaches, devices and combination products, and digital solutions. A large and highly comorbid patient population, fragmented patient journeys, and demand for value-based care create challenges for innovators in the field.
At Health Advances, our experience across sectors helps clients navigate the complex commercial challenges in the cardiovascular market and develop strong value propositions to create competitive advantage.
External Cardiovascular Experts in Our Network
Cross-Sector Digital, MedTech and Combination Product Expertise
And other dedicated Cardiovascular staff and resources
Cardiovascular Case Studies
As it prepared to commercialize its first product and build out its cardiac franchise, a mid-sized pharma company asked Health Advances to develop a portfolio strategy. We fostered internal, cross-functional alignment on recommended disease areas to prioritize. We developed strategic frameworks that could be leveraged by the company to evaluate new disease area opportunities over time. The client used the findings to drive R&D investments and define its near-term strategic plan.
A biotechnology company needed a digital health strategy as they prepared to launch a novel therapeutic in the cardiovascular market. Our team identified and evaluated potential digital health applications and partnerships across the patient journey, and then collaboratively defined the most attractive opportunities through interactive strategy sessions. The project culminated in a roadmap, with compelling rationale on the prioritized digital opportunities and recommendations on promising partners.
For an early-stage biopharmaceutical company, Health Advances assessed the global opportunity and developed sales forecasts for two cardiovascular indications. The final deliverable supported the client's efforts to raise additional funding for its planned Phase III study.
A global life sciences investment fund needed a rapid diligence on a cardiovascular investment opportunity. Our team completed in-depth market assessments and pressure tested critical valuation assumptions, including patient epidemiology, class and competitive shares, pricing, and commercialization cost requirements. The team delivered a succinct management presentation summarizing our recommendations on the opportunity with a supporting forecast highlighting key risks and upside scenarios.
A manufacturer with a novel cardiovascular monitoring technology asked Health Advances to map out a market access strategy to support discussions with investors. We defined and assessed value drivers and willingness to pay among stakeholders in several settings, outlined the patient journey and market access landscape, defined the clinical and economic value story for the client’s technology, and identified likely payment models. Ultimately, we delivered a compelling investor-facing presentation to support fundraising for further development.
Cardiovascular Leadership
- Biotech & Pharmaceuticals
- Diagnostics, Research Tools, & Precision Medicine
- MedTech
- Digital Health & Enterprise HIT
- Investors
News
7/23/2019
Launch of Health Advances Asia Limited Extends APAC Capability
The opening of Health Advances Asia Limited leverages the firm’s 20+ years of experience in the Asia/Pacific region to help both local and multi-national companies looking to expand their global footprint.
Learn MoreNews
2/6/2019
MedTech Expert, Tracy Walters, Promoted to Partner
We are delighted to announce the promotion of "Tracy Walters":/leadership/#tracy-walters to Partner of the firm. Tracy has excelled during her 12.5 years with the firm as one of the senior leaders of the MedTech Practice working with a wide variety of medical device clients ranging from small start-ups to some of the largest public companies in the industry. She is particularly accomplished in product forecasting, financial modeling, and international markets.
Learn MoreNews
11/20/2018
The Boston Globe Names Health Advances a Top Place to Work for 2018
Health Advances has been named one of the Top Places to Work in Massachusetts in the 11th annual employee-based survey project from The Boston Globe.
Learn MoreNews
7/11/2018
Health Advances Team Publishes Compelling Payer Budget Impact Analysis for Tactile Medical
"Julia Gaebler":/leadership/#julia-a-gaebler-phd, Partner, led a team (including Adam Cohen, Engagement Manger; Jessica Izhakoff, Consultant, and Laura Gullett, Senior Analyst) to assess the budget impact to a US commercial health plan of providing access to the Flexitouch (FLX) advanced pneumatic compression device to lymphedema patients with either comorbid chronic venous insufficiency or frequent infections.
Learn MoreNews
7/11/2018
Health Advances Team Publishes Compelling Economic Data for Tactile Medical
"Julia Gaebler":/leadership/#julia-a-gaebler-phd, Partner, led a team (including Michelle Lerman, Engagement Manager; Jessica Izhakoff, Senior Analyst, and Laura Gullett, Senior Analyst) to analyze the economic outcomes and medical resource use associated with Tactile Medical’s Flexitouch device vs. alternative therapies for phlebolymphedema patients.
Learn MoreNews
6/1/2018
Health Advances Celebrates 26 Years
In June of this year, Health Advances will celebrate its 26th Anniversary of supporting clients in the healthcare industry.
Learn MoreNews
6/1/2018
Health Advances’ San Francisco Office Celebrates Ten Years
Health Advances recently celebrated the 10th anniversary of our San Francisco office. The success and rapid growth of this office reflect the strong relationships we have built with clients across biopharma, diagnostics, medical devices, digital health, and private equity.
Learn MoreNews
2/15/2018
Health Advances Hires Three Vice Presidents
Darcy Krzynowek, Balazs Felcsuti, and Ruggero Rossi recently joined Health Advances as Vice Presidents in the Boston area office. “We are delighted to be able to attract these three talented industry leaders to complement our management team. Each of them brings unique skills and experiences that will expand our offerings to clients and enrich our consulting teams,” explained Paula Ness Speers, Co-Founder of Health Advances.
Learn MoreNews
1/18/2018
Winners of the Boston Pediatric Device Strategic Partner Challenge Unveiled
"The Boston Pediatric Device Strategic Partner Challenge(BPDC)":https://www.bostonpdc.org/ attracted an eclectic applicant pool of entrepreneurs and innovators from around the globe.
Learn MoreNews
9/11/2017
Health Advances Partners with Boston Children’s Hospital to Launch Pediatric Device Challenge
Health Advances is proud to be a provider partner to the Boston Pediatric Device Strategic Partner Challenge! This Challenge addresses the critical need for pediatric device development, and we are thrilled to partner with the Boston Pediatric Device Consortium and the Innovation & Digital Health Accelerator at Boston Children’s Hospital to promote this exciting opportunity – see full press release "here":http://www.prnewswire.com/news-releases/boston-childrens-hospital-and-boston-pediatric-device-consortium-launch-pediatric-medical-device-challenge-300517063.html.
Learn MoreNews
4/19/2017
Health Advances Honored by Forbes as One of America’s Best Management Consulting Firms
Health Advances has been honored by Forbes as One of America’s Best Management Consulting Firms for 2017.
Learn MoreNews
2/16/2017
Health Advances Celebrates 25 Years
In June of this year, Health Advances will celebrate its 25th Anniversary of supporting clients in the healthcare industry. We are proud of the fact that the company has stayed true to its initial vision of helping clients commercialize meaningful new products and services that improve the quality and cost-effectiveness of healthcare. We are also proud of the talented employees and alumni/ae who have helped build the firm’s reputation for responsiveness, insight and integrity.
Learn More